Oxymorphone Confirmation, Random, Urine
Use
The Oxymorphone Confirmation, Random, Urine test is used for the detection and quantification of oxymorphone and noroxymorphone in urine. It helps confirm exposure to oxymorphone and oxycodone, as oxymorphone is a metabolite of oxycodone. This test is crucial for monitoring compliance and detecting potential misuse in patients prescribed these opiates. The detection interval for opiates is typically 2 to 3 days after last ingestion.
Special Instructions
Not provided.
Limitations
This test does not detect other opioid class drugs such as fentanyl, meperidine, methadone, or opiate antagonists like naloxone. Improper specimen collection, handling, or test selection might affect results. The test is limited to the detection and quantification of oxymorphone and noroxymorphone, which is a metabolite of oxycodone, potentially leading to false interpretations regarding opiate use if not clinically correlated.
New York Approved
Methodology
Mass Spectrometry (LC-MS/MS)
Biomarkers
Noroxymorphone
AnalyteOxymorphone
Analyte
LOINC Codes
- 94305-0 - OxyMORphone+Noroxymorph Pnl Ur Cfm
- 17395-5 - oxyMORphone Ur Cfm-mCnc
- 69050-3 - Toxicologist review
- 90894-7 - Noroxymorphone Ur Cfm-mCnc
Result Turnaround Time
2-5 days
Related Documents
For more information, please review the documents below
Specimen
Urine
Volume
3 mL
Minimum Volume
2.5 mL
Container
Plastic urine container
Collection Instructions
Collect a random urine specimen with no preservative. Ensure submission container is a plastic 5-mL tube. No specimen substitutions are allowed. Submitting less than 1 mL will compromise testing validity.
Causes for Rejection
None explicitly stated. Gross hemolysis and icterus are acceptable.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 14 days |
| Refrigerated | 28 days |
| Frozen | 28 days |